CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-01 | Harvey Jimmie Director | Grant or award · Deferred Restricted Stock Units | +16,666 | 33,332 | ||
| 2017-01-01 | Harvey Jimmie Director | Grant or award · Deferred Restricted Stock Units | +16,666 | 33,332 | ||
| 2016-12-01 | ROSENWALD LINDSAY A MD President and CEO | Purchase | +731 | $2.03 | $1K | 5,304,470 |
| 2016-09-16 | Avgerinos George SVP, Biologics Operations | Sale | −33,912 | $2.55 | $86K | 259,088 |
| 2016-09-15 | Avgerinos George SVP, Biologics Operations | Sale | −15,000 | $2.54 | $38K | 293,000 |
| 2016-09-14 | Avgerinos George SVP, Biologics Operations | Grant or award | +150,000 | 308,000 | ||
| 2016-07-15 | Klein Dov Director | Returned to the company | −13,333 | 141,667 | ||
| 2016-07-15 | Klein Dov Director | Grant or award · Deferred Restricted Stock Units | +13,333 | 13,333 | ||
| 2016-06-01 | ROSENWALD LINDSAY A MD President and CEO | Purchase | +613 | $2.40 | $1K | 5,303,739 |
| 2016-03-14 | Harvey Jimmie Director | Grant or award · Deferred Restricted Stock Units | +16,666 | 16,666 | ||
| 2016-03-14 | Harvey Jimmie Director | Grant or award · Deferred Restricted Stock Units | +16,666 | 16,666 | ||
| 2016-03-14 | Hoenlein Malcolm Director | Grant or award · Deferred Restricted Stock Units | +16,666 | 16,666 | ||
| 2016-01-01 | ROSENWALD LINDSAY A MD President and CEO | Grant or award | +510,434 | 5,303,126 | ||
| 2016-01-01 | WEISS MICHAEL S Exec. VC - Strategic Dev. | Grant or award | +510,434 | 7,448,472 | ||
| 2016-01-01 | LOBELL J JAY Director | Grant or award | +100,000 | 586,000 | ||
| 2016-01-01 | Rowinsky Eric K Director | Grant or award | +100,000 | 250,000 | ||
| 2016-01-01 | Klein Dov Director | Grant or award | +100,000 | 155,000 | ||
| 2015-12-01 | ROSENWALD LINDSAY A MD President and CEO | Purchase | +586 | $2.41 | $1K | 4,792,692 |
| 2015-09-11 | Avgerinos George SVP, Biologics Operations | Returned to the company | −31,299 | $2.68 | $84K | 158,000 |
| 2015-09-10 | Avgerinos George SVP, Biologics Operations | Returned to the company | −22,737 | $2.62 | $60K | 189,299 |
Page 9 of 12 · 231 trades